{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:02:02Z","timestamp":1791295322999,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7347","license":[{"start":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T00:00:00Z","timestamp":1305676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T00:00:00Z","timestamp":1305676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2011,5,19]]},"DOI":"10.1038\/nature09883","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T04:54:50Z","timestamp":1305608090000},"page":"384-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":184,"title":["BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR\u2013ABL1 kinase inhibition"],"prefix":"10.1038","volume":"473","author":[{"given":"Cihangir","family":"Duy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmehdi","family":"Shojaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Cerchietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividya","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-mi","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Braig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Karsten","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Jumaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Phillip","family":"Koeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jessica","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Heisterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Graeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Hilda","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00fcschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,18]]},"reference":[{"key":"BFnature09883_CR1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker, B. J. et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038\u20131042 (2001)","journal-title":"N. Engl. J. Med."},{"key":"BFnature09883_CR2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1535-6108(03)00003-5","volume":"3","author":"SA Armstrong","year":"2003","unstructured":"Armstrong, S. A. et al. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 3, 173\u2013183 (2003)","journal-title":"Cancer Cell"},{"key":"BFnature09883_CR3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/379645a0","volume":"379","author":"N Meydan","year":"1996","unstructured":"Meydan, N. et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379, 645\u2013648 (1996)","journal-title":"Nature"},{"key":"BFnature09883_CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","volume":"305","author":"NP Shah","year":"2004","unstructured":"Shah, N. P. et al. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 305, 399\u2013401 (2004)","journal-title":"Science"},{"key":"BFnature09883_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","volume":"16","author":"T O\u2019Hare","year":"2009","unstructured":"O\u2019Hare, T. et al. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell 16, 401\u2013412 (2009)","journal-title":"Cancer Cell"},{"key":"BFnature09883_CR6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham, S. M. et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro . Blood 99, 319\u2013325 (2002)","journal-title":"Blood"},{"key":"BFnature09883_CR7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka, K. et al. TGF-\u03b2-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463, 676\u2013680 (2010)","journal-title":"Nature"},{"key":"BFnature09883_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ccr.2009.06.007","volume":"16","author":"KI Oravecz-Wilson","year":"2009","unstructured":"Oravecz-Wilson, K. I. et al. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer Cell 16, 137\u2013148 (2009)","journal-title":"Cancer Cell"},{"key":"BFnature09883_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ccr.2007.08.011","volume":"12","author":"M Saito","year":"2007","unstructured":"Saito, M. et al. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 12, 280\u2013292 (2007)","journal-title":"Cancer Cell"},{"key":"BFnature09883_CR10","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.0900780106","volume":"106","author":"CA Pratilas","year":"2009","unstructured":"Pratilas, C. A. et al. (V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway. Proc. Natl Acad. Sci. USA 106, 4519\u20134524 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature09883_CR11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.molcel.2009.09.019","volume":"36","author":"C Choudhary","year":"2009","unstructured":"Choudhary, C. et al. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol. Cell 36, 326\u2013339 (2009)","journal-title":"Mol. Cell"},{"key":"BFnature09883_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm.2091","volume":"16","author":"MR Janes","year":"2010","unstructured":"Janes, M. R. et al. Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor. Nature Med. 16, 205\u2013213 (2010)","journal-title":"Nature Med."},{"key":"BFnature09883_CR13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.onc.1209775","volume":"26","author":"SR Walker","year":"2007","unstructured":"Walker, S. R., Nelson, E. A. & Frank, D. A. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene 26, 224\u2013233 (2007)","journal-title":"Oncogene"},{"key":"BFnature09883_CR14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20091299","volume":"207","author":"C Duy","year":"2010","unstructured":"Duy, C. et al. BCL6 is critical for the development of a diverse primary B cell repertoire. J. Exp. Med. 207, 1209\u20131221 (2010)","journal-title":"J. Exp. Med."},{"key":"BFnature09883_CR15","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1128\/MCB.24.22.10058-10071.2004","volume":"24","author":"S Fernandez de Mattos","year":"2004","unstructured":"Fernandez de Mattos, S. et al. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5\/BCL6-dependent mechanism. Mol. Cell. Biol. 24, 10058\u201310071 (2004)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature09883_CR16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nature03147","volume":"432","author":"RT Phan","year":"2004","unstructured":"Phan, R. T. & Dalla-Favera, R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432, 635\u2013639 (2004)","journal-title":"Nature"},{"key":"BFnature09883_CR17","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1073\/pnas.0602402103","volume":"103","author":"HG Wendel","year":"2006","unstructured":"Wendel, H. G. et al. Loss of p53 impedes the antileukemic response to BCR-ABL inhibition. Proc. Natl Acad. Sci. USA 103, 7444\u20137449 (2006)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature09883_CR18","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4161\/cc.3.9.1126","volume":"3","author":"Z Goldberg","year":"2004","unstructured":"Goldberg, Z., Levav, Y., Krichevsky, S., Fibach, E. & Haupt, Y. Treatment of chronic myeloid leukemia cells with imatinib (STI571) impairs p53 accumulation in response to DNA damage. Cell Cycle 3, 1188\u20131195 (2004)","journal-title":"Cell Cycle"},{"key":"BFnature09883_CR19","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1158\/0008-5472.CAN-09-0548","volume":"69","author":"I Skorta","year":"2009","unstructured":"Skorta, I. et al. Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activity. Cancer Res. 69, 9337\u20139345 (2009)","journal-title":"Cancer Res."},{"key":"BFnature09883_CR20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","volume":"91","author":"T Kamijo","year":"1997","unstructured":"Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649\u2013659 (1997)","journal-title":"Cell"},{"key":"BFnature09883_CR21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature03841","volume":"436","author":"M Braig","year":"2005","unstructured":"Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660\u2013665 (2005)","journal-title":"Nature"},{"key":"BFnature09883_CR22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","volume":"322","author":"CG Mullighan","year":"2008","unstructured":"Mullighan, C. G. et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322, 1377\u20131380 (2008)","journal-title":"Science"},{"key":"BFnature09883_CR23","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.0602030103","volume":"103","author":"RT Williams","year":"2006","unstructured":"Williams, R. T., Roussel, M. F. & Sherr, C. J. Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA 103, 6688\u20136693 (2006)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature09883_CR24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","volume":"12","author":"DS Krause","year":"2006","unstructured":"Krause, D. S., Lazarides, K., von Andrian, U. H. & Van Etten, R. A. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nature Med. 12, 1175\u20131180 (2006)","journal-title":"Nature Med."},{"key":"BFnature09883_CR25","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1182\/blood-2008-07-168773","volume":"113","author":"LC Cerchietti","year":"2009","unstructured":"Cerchietti, L. C. et al. A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo . Blood 113, 3397\u20133405 (2009)","journal-title":"Blood"},{"key":"BFnature09883_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","volume":"13","author":"AL Shaffer","year":"2000","unstructured":"Shaffer, A. L. et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13, 199\u2013212 (2000)","journal-title":"Immunity"},{"key":"BFnature09883_CR27","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1101\/gad.1588607","volume":"21","author":"RT Williams","year":"2007","unstructured":"Williams, R. T. den, B. W. & Sherr, C. J. Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia. Genes Dev. 21, 2283\u20132287 (2007)","journal-title":"Genes Dev."},{"key":"BFnature09883_CR28","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1158\/0008-5472.CAN-10-1438","volume":"70","author":"TA Gruber","year":"2010","unstructured":"Gruber, T. A., Chang, M. S., Sposto, R. & Muschen, M. Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia. Cancer Res. 70, 7411\u20137420 (2010)","journal-title":"Cancer Res."},{"key":"BFnature09883_CR29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ccr.2009.12.050","volume":"17","author":"LC Cerchietti","year":"2010","unstructured":"Cerchietti, L. C. et al. A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo . Cancer Cell 17, 400\u2013411 (2010)","journal-title":"Cancer Cell"},{"key":"BFnature09883_CR30","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear, W. S. et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 92, 3780\u20133792 (1998)","journal-title":"Blood"},{"key":"BFnature09883_CR31","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/MCB.18.7.3871","volume":"18","author":"M Onishi","year":"1998","unstructured":"Onishi, M. et al. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18, 3871\u20133879 (1998)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature09883_CR32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2008.06.006","volume":"134","author":"S Godar","year":"2008","unstructured":"Godar, S. et al. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell 134, 62\u201373 (2008)","journal-title":"Cell"},{"key":"BFnature09883_CR33","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1101\/gad.1848209","volume":"23","author":"MS Kumar","year":"2009","unstructured":"Kumar, M. S. et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 23, 2700\u20132704 (2009)","journal-title":"Genes Dev."},{"key":"BFnature09883_CR34","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/nar\/23.4.628","volume":"23","author":"Y Soneoka","year":"1995","unstructured":"Soneoka, Y. et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628\u2013633 (1995)","journal-title":"Nucleic Acids Res."},{"key":"BFnature09883_CR35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1126\/science.276.5312.589","volume":"276","author":"AL Dent","year":"1997","unstructured":"Dent, A. L., Shaffer, A. L., Yu, X., Allman, D. & Staudt, L. M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276, 589\u2013592 (1997)","journal-title":"Science"},{"key":"BFnature09883_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng0697-161","volume":"16","author":"BH Ye","year":"1997","unstructured":"Ye, B. H. et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nature Genet. 16, 161\u2013170 (1997)","journal-title":"Nature Genet."},{"key":"BFnature09883_CR37","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1128\/MCB.24.18.8037-8047.2004","volume":"24","author":"Y Cui","year":"2004","unstructured":"Cui, Y. et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell. Biol. 24, 8037\u20138047 (2004)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature09883_CR38","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1126\/science.1065518","volume":"294","author":"M Groszer","year":"2001","unstructured":"Groszer, M. et al. Negative regulation of neural stem\/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294, 2186\u20132189 (2001)","journal-title":"Science"},{"key":"BFnature09883_CR39","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S1097-2765(03)00454-4","volume":"12","author":"KF Ahmad","year":"2003","unstructured":"Ahmad, K. F. et al. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol. Cell 12, 1551\u20131564 (2003)","journal-title":"Mol. Cell"},{"key":"BFnature09883_CR40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molcel.2007.12.026","volume":"29","author":"AF Ghetu","year":"2008","unstructured":"Ghetu, A. F. et al. Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer. Mol. Cell 29, 384\u2013391 (2008)","journal-title":"Mol. Cell"},{"key":"BFnature09883_CR41","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nm1134","volume":"10","author":"JM Polo","year":"2004","unstructured":"Polo, J. M. et al. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nature Med. 10, 1329\u20131335 (2004)","journal-title":"Nature Med."},{"key":"BFnature09883_CR42","unstructured":"Chakravarti, L. &. Roy, (1967). Handbook of Methods of Applied Statistics, Volume I, John Wiley and Sons, pp. 392-394. (1967)"},{"key":"BFnature09883_CR43","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1182\/blood-2008-12-193037","volume":"113","author":"W Ci","year":"2009","unstructured":"Ci, W. et al. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL. Blood 113, 5536\u20135548 (2009)","journal-title":"Blood"},{"key":"BFnature09883_CR44","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0611399104","volume":"104","author":"JM Polo","year":"2007","unstructured":"Polo, J. M. et al. Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas. Proc. Natl Acad. Sci. USA 104, 3207\u20133212 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature09883_CR45","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20090004","volume":"206","author":"D Trageser","year":"2009","unstructured":"Trageser, D. et al. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J. Exp. Med. 206, 1739\u20131753 (2009)","journal-title":"J. Exp. Med."}],"updated-by":[{"DOI":"10.1038\/s41586-026-10253-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature09883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature09883","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature09883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:43:47Z","timestamp":1771825427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature09883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,18]]},"references-count":45,"journal-issue":{"issue":"7347","published-print":{"date-parts":[[2011,5,19]]}},"alternative-id":["BFnature09883"],"URL":"https:\/\/doi.org\/10.1038\/nature09883","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10707956.11638054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.10707956.12017059","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,18]]},"assertion":[{"value":"1 February 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-026-10253-9","URL":"https:\/\/doi.org\/10.1038\/s41586-026-10253-9","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}